IO Biotech Q2 EPS $(0.74) Down From $(0.64) YoY
Portfolio Pulse from Benzinga Newsdesk
IO Biotech (NASDAQ:IOBT) reported a 15.62% increase in its quarterly losses, with EPS of $(0.74) compared to $(0.64) in the same period last year.
August 11, 2023 | 12:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IO Biotech's Q2 losses have increased by 15.62% compared to the same period last year, indicating a negative financial performance.
IO Biotech's increased losses indicate a negative financial performance, which could potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100